A phase II, randomized trial (CONCERT-1) of chemoradiotherapy (CRT) with or without panitumumab (pmab) in patients (pts) with unresected, locally advanced squamous cell carcinoma of the head and neck (LASCCHN). Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Giralt, Jordi
  • Fortin, Andre
  • Mesia, Ricard
  • Minn, Heikki
  • Henke, Michael
  • Ancona, Alejandro Yunes
  • Cmelak, Anthony
  • Markowitz, Avi B
  • Hotte, Sebastien
  • Singh, Simron
  • Chan, Anthony TC
  • Merlano, Marco Carlo
  • Zhang, Alicia
  • Oliner, Kelly S
  • Vanderwalde, Ari M

publication date

  • May 20, 2012